Syncona Portfolio LTD Autolus Therapeutics PLC Transaction History
Syncona Portfolio LTD
- $53 Million
- Q4 2024
A detailed history of Syncona Portfolio LTD transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Syncona Portfolio LTD holds 16,640,720 shares of AUTL stock, worth $32.4 Million. This represents 73.83% of its overall portfolio holdings.
Number of Shares
16,640,720
Previous 18,554,624
10.31%
Holding current value
$32.4 Million
Previous $67.4 Million
41.94%
% of portfolio
73.83%
Previous 83.42%
Shares
4 transactions
Others Institutions Holding AUTL
# of Institutions
112Shares Held
156MCall Options Held
0Put Options Held
116K-
Wellington Management Group LLP Boston, MA25.3MShares$49.4 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$39.9 Million0.24% of portfolio
-
Deep Track Capital, LP Greenwich, CT14.2MShares$27.7 Million1.47% of portfolio
-
Avoro Capital Advisors LLC New York, NY9.91MShares$19.3 Million0.34% of portfolio
-
Armistice Capital, LLC New York, NY9.2MShares$17.9 Million0.31% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $177M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...